{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:29:20Z","timestamp":1793928560599,"version":"4.8.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Bone mineral deficits are one of the most common complications in cancer survivors. However, there are no studies evaluating bone mineral density (BMD) and the prevalence of osteopenia and osteoporosis among patients with different types of cancers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>The objective was to assess BMD and evaluate the prevalence of osteopenia and osteoporosis among US adults with cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>A cross-section propensity score matching study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We extracted data from National Health and Nutrition Examination Survey database from 2005 to 2018. We compared BMD in participants with and without cancer which was further analyzed according to cancer type. We conducted logistic regression to evaluate adjusted odds ratios of osteopenia and osteoporosis and determine risk factors for their development.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We found that BMD was significantly higher in participants without cancer than cancer patients. Furthermore, the median BMD of patients with breast cancer or skin cancer (including melanoma) was significantly lower than participants without cancer. People with breast, lung, genitourinary and skin cancers were more likely to incur osteopenia\/osteoporosis than those without cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>BMD differs depending upon type in survivors. Individuals with a history of cancer have a poor understanding of osteoporosis and its risk factors. Understanding risk factors in patients with cancers identified in our study may be helpful for preventing osteoporosis and fractures and the development of screening guidelines.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/qjmed\/hcac015","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T12:12:45Z","timestamp":1643199165000},"page":"653-660","source":"Crossref","is-referenced-by-count":31,"title":["Bone mineral density, osteopenia and osteoporosis among US adults with cancer"],"prefix":"10.1093","volume":"115","author":[{"given":"J -F","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, Xijing Hospital, The Air Force Medical University , No. 17 Changle Xi Road, Xi\u2019an, Shaanxi Province 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q -C","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Xijing Hospital, The Air Force Medical University , No. 17 Changle Xi Road, Xi\u2019an, Shaanxi Province 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Xijing Hospital, The Air Force Medical University , No. 17 Changle Xi Road, Xi\u2019an, Shaanxi Province 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Xijing Hospital, The Air Force Medical University , No. 17 Changle Xi Road, Xi\u2019an, Shaanxi Province 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bergman","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, VA New York Harbor Healthcare System, NYU Grossman School of Medicine, 423 East 23rd Street, New York, NY 10010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0357-0450","authenticated-orcid":false,"given":"Z","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Xijing Hospital, The Air Force Medical University , No. 17 Changle Xi Road, Xi\u2019an, Shaanxi Province 710032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"2022102511022290000_hcac015-B1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41574-019-0220-8","article-title":"Fracture prediction, imaging and screening in osteoporosis","volume":"15","author":"Fuggle","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"2022102511022290000_hcac015-B2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice. Postmenopausal osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N Engl J Med"},{"key":"2022102511022290000_hcac015-B3","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"J Bone Min Res"},{"key":"2022102511022290000_hcac015-B4","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s00198-017-3996-1","article-title":"Trends in osteoporosis and low bone mass in older US adults, 2005-2006 through 2013-2014","volume":"28","author":"Looker","year":"2017","journal-title":"Osteoporos Int"},{"key":"2022102511022290000_hcac015-B5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Min Res"},{"key":"2022102511022290000_hcac015-B6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1470-2045(13)70244-4","article-title":"Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis","volume":"14","author":"Mitchell","year":"2013","journal-title":"Lancet Oncol"},{"key":"2022102511022290000_hcac015-B7","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"2022102511022290000_hcac015-B8","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1200\/JCO.2017.76.3268","article-title":"Endocrine late effects in childhood cancer survivors","volume":"36","author":"Chemaitilly","year":"2018","journal-title":"J Clin Oncol"},{"key":"2022102511022290000_hcac015-B9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11657-020-00863-9","article-title":"A long-term trajectory of bone mineral density in childhood cancer survivors after discontinuation of treatment: retrospective cohort study","volume":"16","author":"Latoch","year":"2021","journal-title":"Arch Osteoporos"},{"key":"2022102511022290000_hcac015-B10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00198-014-2878-z","article-title":"Bone mineral density after childhood cancer in 346 long-term adult survivors of childhood cancer","volume":"26","author":"den Hoed","year":"2015","journal-title":"Osteoporos Int"},{"key":"2022102511022290000_hcac015-B11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-8587(21)00173-X","article-title":"Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"9","author":"van Atteveld","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022102511022290000_hcac015-B12","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/jbmr.4250","article-title":"Bone mineral density at the time of initiating aromatase inhibitor therapy is associated with decreased fractures in women with breast cancer","volume":"36","author":"Lu","year":"2021","journal-title":"J Bone Min Res"},{"key":"2022102511022290000_hcac015-B13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00198-018-4758-4","article-title":"Hormone therapy and osteoporosis in breast cancer survivors: assessment of risk and adherence to screening recommendations","volume":"30","author":"Hamood","year":"2019","journal-title":"Osteoporos Int"},{"key":"2022102511022290000_hcac015-B14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00774-018-0917-0","article-title":"Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer","volume":"37","author":"Nakatsukasa","year":"2019","journal-title":"J Bone Min Metab"},{"key":"2022102511022290000_hcac015-B15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.maturitas.2014.08.001","article-title":"Screening for osteoporosis after breast cancer: for whom, why and when","volume":"79","author":"Tr\u00e9mollieres","year":"2014","journal-title":"Maturitas"},{"key":"2022102511022290000_hcac015-B16","first-page":"1","article-title":"National health and nutrition examination survey: plan and operations, 1999-2010","author":"Zipf","year":"2013","journal-title":"Vital Health Stat 1"},{"key":"2022102511022290000_hcac015-B17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jbmr.5650090621","article-title":"Quality control of bone densitometry in a national health survey (NHANES III) using three mobile examination centers","volume":"9","author":"Wahner","year":"1994","journal-title":"J Bone Min Res"},{"key":"2022102511022290000_hcac015-B18","doi-asserted-by":"crossref","first-page":"8852690","DOI":"10.1155\/2020\/8852690","article-title":"Association between bone mineral density and severity of chronic kidney disease","volume":"2020","author":"Huang","year":"2020","journal-title":"Int J Endocrinol"},{"key":"2022102511022290000_hcac015-B19","doi-asserted-by":"crossref","first-page":"e2613","DOI":"10.1210\/clinem\/dgab180","article-title":"An updated reference for calculating bone mineral density T-scores","volume":"106","author":"Xue","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2022102511022290000_hcac015-B20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","article-title":"A reference standard for the description of osteoporosis","volume":"42","author":"Kanis","year":"2008","journal-title":"Bone"},{"key":"2022102511022290000_hcac015-B21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"2022102511022290000_hcac015-B22","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1200\/JCO.2012.42.2097","article-title":"Bone health in adult cancer survivorship","volume":"30","author":"Lustberg","year":"2012","journal-title":"J Clin Oncol"},{"key":"2022102511022290000_hcac015-B23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/pbc.21908","article-title":"Pediatric Hodgkin lymphoma survivors at negligible risk for significant bone mineral density deficits","volume":"52","author":"Kaste","year":"2009","journal-title":"Pediatric Blood Cancer"},{"key":"2022102511022290000_hcac015-B24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/bmt.2016.345","article-title":"Skeletal outcome in long-term survivors of childhood high-risk neuroblastoma treated with high-dose therapy and autologous stem cell rescue","volume":"52","author":"Utriainen","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"2022102511022290000_hcac015-B25","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/pbc.23166","article-title":"Reduced bone mineral density in adult patients with Langerhans cell histiocytosis","volume":"58","author":"Makras","year":"2012","journal-title":"Pediatric Blood Cancer"},{"key":"2022102511022290000_hcac015-B26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/08880018.2015.1048912","article-title":"Pediatric survivors of retinoblastoma are at risk for altered bone metabolism after chemotherapy treatment early in life","volume":"32","author":"Sch\u00fcndeln","year":"2015","journal-title":"Pediatric Hematol Oncol"},{"key":"2022102511022290000_hcac015-B27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00774-017-0856-1","article-title":"Bone health in long-term gastric cancer survivors: a prospective study of high-dose vitamin D supplementation using an easy administration scheme","volume":"36","author":"Climent","year":"2018","journal-title":"J Bone Min Metab"},{"key":"2022102511022290000_hcac015-B28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S8756-3282(00)00404-X","article-title":"Bone mineral metabolism after total gastrectomy","volume":"28","author":"Heiskanen","year":"2001","journal-title":"Bone"},{"key":"2022102511022290000_hcac015-B29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.maturitas.2016.10.007","article-title":"Osteoporosis management in patients with breast cancer: EMAS position statement","volume":"95","author":"Tr\u00e9mollieres","year":"2017","journal-title":"Maturitas"},{"key":"2022102511022290000_hcac015-B30","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1359\/jbmr.060508","article-title":"Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230)","volume":"21","author":"Eastell","year":"2006","journal-title":"J Bone Min Res"},{"key":"2022102511022290000_hcac015-B31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1470-2045(07)70003-7","article-title":"Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study","volume":"8","author":"Coleman","year":"2007","journal-title":"Lancet Oncol"},{"key":"2022102511022290000_hcac015-B32","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/jnci\/dji250","article-title":"Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17","volume":"97","author":"Goss","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2022102511022290000_hcac015-B33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bone.2006.06.027","article-title":"Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane","volume":"40","author":"Gonnelli","year":"2007","journal-title":"Bone"},{"key":"2022102511022290000_hcac015-B34","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/annonc\/mdn762","article-title":"Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy","volume":"20","author":"Hadji","year":"2009","journal-title":"Ann Oncol"},{"key":"2022102511022290000_hcac015-B35","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/jbmr.3726","article-title":"Performance of FRAX in women with breast cancer initiating aromatase inhibitor therapy: a registry-based cohort study","volume":"34","author":"Leslie","year":"2019","journal-title":"J Bone Min Res"},{"key":"2022102511022290000_hcac015-B36","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/jbmr.4391","article-title":"Individualized bone-protective management in long-term cancer survivors with bone metastases","volume":"36","author":"Rachner","year":"2021","journal-title":"J Bone Min Res"},{"key":"2022102511022290000_hcac015-B37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1634\/theoncologist.2012-0416","article-title":"A study to evaluate the cause of bone demineralization in gynecological cancer survivors","volume":"18","author":"Stavraka","year":"2013","journal-title":"Oncologist"},{"key":"2022102511022290000_hcac015-B38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jneb.2007.08.009","article-title":"Are cancer survivors\/patients knowledgeable about osteoporosis? Results from a survey of 285 chemotherapy-treated cancer patients and their companions","volume":"40","author":"McKean","year":"2008","journal-title":"J Nutr Educ Behav"}],"container-title":["QJM: An International Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/qjmed\/advance-article-pdf\/doi\/10.1093\/qjmed\/hcac015\/42358625\/hcac015.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/115\/10\/653\/46620547\/hcac015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/qjmed\/article-pdf\/115\/10\/653\/46620547\/hcac015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T11:03:11Z","timestamp":1666695791000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/qjmed\/article\/115\/10\/653\/6517211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,1,29]]},"published-print":{"date-parts":[[2022,10,25]]}},"URL":"https:\/\/doi.org\/10.1093\/qjmed\/hcac015","relation":{},"ISSN":["1460-2725","1460-2393"],"issn-type":[{"value":"1460-2725","type":"print"},{"value":"1460-2393","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,1,29]]}}}